ACRAL LENTIGINOUS MELANOMA
Clinical trials for ACRAL LENTIGINOUS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new ACRAL LENTIGINOUS MELANOMA trials appear
Sign up with your email to follow new studies for ACRAL LENTIGINOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-Dose hope for devastating brain cancer spread
Disease control OngoingThis early-stage trial is testing a new way to give an immunotherapy drug called nivolumab to patients with melanoma or lung cancer that has spread to the membranes surrounding the brain and spinal cord. The goal is to see if giving the drug directly into the spinal fluid, along …
Matched conditions: ACRAL LENTIGINOUS MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug trial aims to extend life for advanced melanoma patients
Disease control OngoingThis study is testing an experimental drug called dinaciclib in people with stage IV melanoma that has spread. The main goal is to see if the treatment helps patients live at least one year longer. Researchers will also monitor how well it controls the cancer's growth and what si…
Matched conditions: ACRAL LENTIGINOUS MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New strategy: shrink tumors before surgery to fight advanced melanoma
Disease control OngoingThis study is comparing two different timing strategies for an immunotherapy drug called pembrolizumab in patients with high-risk melanoma that can be surgically removed. It aims to see if giving the drug *before* surgery (to shrink the tumor) works better than the standard appro…
Matched conditions: ACRAL LENTIGINOUS MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC